These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23621265)

  • 41. Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.
    Li K; Li W
    Mol Cell Biochem; 2013 Jan; 372(1-2):27-33. PubMed ID: 22983827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
    Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
    Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA repair gene XRCC1 and XPD polymorphisms and the risk of idiopathic azoospermia in a Chinese population.
    Gu A; Ji G; Liang J; Xia Y; Lu N; Wu B; Wang W; Song L; Wang S; Wang X
    Int J Mol Med; 2007 Nov; 20(5):743-7. PubMed ID: 17912469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Yuan P; Liu L; Wu C; Zhong R; Yu D; Wu J; Xu Y; Nie S; Miao X; Sun Y; Xu B; Lin D
    Cancer Biol Ther; 2010 Nov; 10(9):854-9. PubMed ID: 20814250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy.
    Zhang L; Ma W; Li Y; Wu J; Shi GY
    Genet Mol Res; 2014 Jan; 13(1):228-36. PubMed ID: 24446315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
    Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
    Malisic E; Jankovic R; Jakovljevic K; Radulovic S
    J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.
    Zavarikina TM; Khokhlova SV; Tyulyandina AS; Khabas GN; Asaturova AV; Nosova YV; Brenner PK; Kapralova MA; Khodirev DS; Stenina MB
    Bull Exp Biol Med; 2021 Oct; 171(6):755-759. PubMed ID: 34709513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women.
    Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Wilczak M; Romanowicz H
    Tumour Biol; 2014 Apr; 35(4):3495-502. PubMed ID: 24402573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy.
    Miao J; Zhang X; Tang QL; Wang XY; Kai L
    Asian Pac J Cancer Prev; 2012; 13(10):5007-10. PubMed ID: 23244100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.
    Cheng CX; Xue M; Li K; Li WS
    Asian Pac J Cancer Prev; 2012; 13(6):2541-5. PubMed ID: 22938418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
    El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
    Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer.
    Krivak TC; Darcy KM; Tian C; Armstrong D; Baysal BE; Gallion H; Ambrosone CB; DeLoia JA;
    J Clin Oncol; 2008 Jul; 26(21):3598-606. PubMed ID: 18640939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
    Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
    J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
    Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
    PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphisms of DNA repair genes and lung cancer in chromium exposure.
    Sarlinova M; Majerova L; Matakova T; Musak L; Slovakova P; Skereňová M; Kavcová E; Halašová E
    Adv Exp Med Biol; 2015; 833():1-8. PubMed ID: 25300687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA repair gene (XRCC1 and XPD) polymorphism and risk of primary ovarian failure.
    Kali Z; Cagiran FT; Kirici P; Dogan C; Celik O
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6593-6599. PubMed ID: 36196709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer.
    Lin K; Ye D; Xie X
    Int J Gynecol Cancer; 2008; 18(5):1007-12. PubMed ID: 18081788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
    Przybylowska-Sygut K; Stanczyk M; Kusinska R; Kordek R; Majsterek I
    Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.